Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Endocrinol ; 152(1): 95-101, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15762192

ABSTRACT

OBJECTIVE: To study possible mechanisms for the inhibition of cytochrome P450 C21 (steroid 21-hydroxylase) enzyme activity by P450 C21 autoantibodies (Abs) in vitro. DESIGN: Two possible mechanisms for the inhibition of P450 C21 enzyme activity by P450 C21 Abs were studied: (a) conformational changes in the P450 C21 molecule induced by Ab binding and (b) the effects of Ab binding to P450 C21 on the electron transfer from the nicotinamide adenine dinucleotide phosphate reduced (NADPH) cytochrome P450 reductase (CPR) to P450 C21. METHODS: The effect of P450 C21 Ab binding on the conformation of recombinant P450 C21 in yeast microsomes was studied using an analysis of the dithionite-reduced CO difference spectra. The effect of P450 C21 Abs on electron transfer was assessed by analysis of reduction of P450 C21 in the microsomes in the presence of CO after addition of NADPH. RESULTS: Our studies confirmed the inhibiting effect of P450 C21 Abs on P450 C21 enzyme activity. Binding of the Abs did not induce significant change in the P450 C21 peak at 450nm (native form) and did not produce a detectable peak at 420 nm (denatured form) in the dithionite-reduced CO difference spectra. This indicated that conformation of P450 C21 around the heme was not altered compared with the native structure. However, incubation of the P450 C21 in yeast microsomes with P450 C21 Ab inhibited the fast phase electron transfer from the CPR to P450 C21. CONCLUSIONS: Our observations suggested that the mechanism by which P450 C21 Abs inhibit P450 C21 enzyme activity most likely involves inhibition of the interaction between the CPR and P450 C21.


Subject(s)
Addison Disease/enzymology , Autoantibodies/metabolism , Steroid 21-Hydroxylase/antagonists & inhibitors , Addison Disease/immunology , Carbon Monoxide/pharmacology , Dithionite , Humans , Immunoglobulin G/metabolism , Microsomes/metabolism , NADPH-Ferrihemoprotein Reductase/metabolism , Oxidation-Reduction , Protein Conformation , Recombinant Proteins/antagonists & inhibitors , Recombinant Proteins/chemistry , Recombinant Proteins/immunology , Recombinant Proteins/metabolism , Spectrophotometry, Ultraviolet/methods , Steroid 21-Hydroxylase/chemistry , Steroid 21-Hydroxylase/immunology , Steroid 21-Hydroxylase/metabolism
2.
J Endocrinol Invest ; 27(7): 618-21, 2004.
Article in English | MEDLINE | ID: mdl-15505983

ABSTRACT

We describe the case of a baby born to a mother with Addison's disease in the context of Autoimmune Polyendocrine Syndrome Type 2. Adrenal cortex autoantibodies and steroid 21-hydroxylase autoantibodies were detectable in the sera of both mother and baby, suggesting the transplacental passage of these autoantibodies. Adrenal autoantibodies were present in the baby's serum at delivery, at 3, 6 and till 34 months of age but no signs of clinical or subclinical adrenal insufficiency were found in the baby during the observation period. These data suggest that the presence of adrenal autoantibodies in serum alone is not a sufficient cause for the development of autoimmune adrenalitis.


Subject(s)
Addison Disease , Adrenal Cortex/physiology , Autoantibodies/analysis , Maternal-Fetal Exchange , Polyendocrinopathies, Autoimmune/complications , Polyendocrinopathies, Autoimmune/immunology , Pregnancy Complications , Adrenal Insufficiency , Adult , Female , Humans , Infant, Newborn , Male , Pregnancy
SELECTION OF CITATIONS
SEARCH DETAIL
...